Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,275 | 677 | 99.6% |
| Education | $55.70 | 6 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,177 | 61 | $0 (2024) |
| Novo Nordisk Inc | $1,049 | 58 | $0 (2024) |
| Amarin Pharma Inc. | $1,046 | 61 | $0 (2022) |
| ACADIA Pharmaceuticals Inc | $752.51 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $670.91 | 36 | $0 (2024) |
| Allergan Inc. | $631.23 | 24 | $0 (2019) |
| ARBOR PHARMACEUTICALS, INC. | $626.89 | 53 | $0 (2021) |
| ABBVIE INC. | $561.92 | 42 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $514.18 | 11 | $0 (2024) |
| PFIZER INC. | $441.97 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,527 | 68 | ABBVIE INC. ($417.47) |
| 2023 | $1,310 | 53 | ACADIA Pharmaceuticals Inc ($494.88) |
| 2022 | $730.41 | 44 | Novartis Pharmaceuticals Corporation ($130.90) |
| 2021 | $1,642 | 108 | Amarin Pharma Inc. ($376.49) |
| 2020 | $1,785 | 113 | Amarin Pharma Inc. ($404.82) |
| 2019 | $1,800 | 85 | Novo Nordisk Inc ($313.88) |
| 2018 | $1,067 | 77 | ARBOR PHARMACEUTICALS, INC. ($179.95) |
| 2017 | $3,469 | 135 | AstraZeneca Pharmaceuticals LP ($331.50) |
All Payment Transactions
683 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Cardiology | ||||||
| 12/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.64 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/05/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.58 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.46 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $104.37 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 09/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $122.83 | General |
| Category: Gastroenterology | ||||||
| 09/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.34 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Obesity | ||||||
| 09/17/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 09/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $0.77 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: DIABETES | ||||||
| 08/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.71 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,111 | 2,168 | $255,140 | $120,460 |
| 2022 | 16 | 1,027 | 1,867 | $226,830 | $106,243 |
| 2021 | 18 | 1,028 | 1,786 | $221,150 | $102,303 |
| 2020 | 20 | 1,110 | 1,977 | $254,655 | $101,745 |
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 178 | 599 | $104,825 | $61,564 | 58.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 112 | 112 | $30,800 | $15,926 | 51.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 181 | $45,250 | $12,111 | 26.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 149 | 391 | $25,415 | $6,863 | 27.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 81 | 81 | $8,100 | $5,826 | 71.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 77 | $8,085 | $5,366 | 66.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 85 | 86 | $3,010 | $2,921 | 97.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 177 | 278 | $4,170 | $2,335 | 56.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 16 | 17 | $5,950 | $1,675 | 28.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 15 | $3,000 | $1,335 | 44.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 53 | 105 | $4,725 | $1,210 | 25.6% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 20 | 23 | $1,955 | $922.33 | 47.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 30 | 35 | $1,325 | $897.39 | 67.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 57 | 68 | $5,440 | $771.60 | 14.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 13 | 14 | $510.00 | $376.32 | 73.8% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 22 | 37 | $1,110 | $305.52 | 27.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 29 | 49 | $1,470 | $54.36 | 3.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 171 | 502 | $87,850 | $51,077 | 58.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 96 | 96 | $26,400 | $14,015 | 53.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 24 | 162 | $40,500 | $9,909 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 78 | 119 | $12,495 | $8,411 | 67.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 79 | 80 | $8,000 | $5,483 | 68.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 126 | 279 | $18,135 | $5,048 | 27.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 23 | 27 | $5,400 | $2,947 | 54.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 83 | 84 | $2,940 | $2,830 | 96.3% |
About Dr. John Anton, M.D
Dr. John Anton, M.D is a Internal Medicine healthcare provider based in Livingston, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780603613.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Anton, M.D has received a total of $13,331 in payments from pharmaceutical and medical device companies, with $1,527 received in 2024. These payments were reported across 683 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($13,275).
As a Medicare-enrolled provider, Anton has provided services to 4,276 Medicare beneficiaries, totaling 7,798 services with total Medicare billing of $430,751. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Livingston, NJ
- Active Since 07/19/2006
- Last Updated 08/18/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1780603613
Products in Payments
- Vascepa (Drug) $1,046
- FARXIGA (Drug) $861.95
- NUPLAZID (Drug) $752.51
- VRAYLAR (Drug) $683.34
- ENTRESTO (Drug) $552.72
- XIFAXAN (Drug) $527.26
- Ozempic (Drug) $371.52
- ELIQUIS (Drug) $323.28
- XARELTO (Drug) $320.54
- Repatha (Biological) $303.29
- Livalo (Drug) $303.26
- INJECTAFER (Drug) $277.86
- Edarbyclor (Drug) $277.04
- Saxenda (Drug) $222.03
- AVYCAZ (Drug) $220.57
- Edarbi (Drug) $216.63
- Santyl (Drug) $213.42
- Natesto (Drug) $210.75
- JANUVIA (Drug) $180.92
- PRALUENT ALIROCUMAB INJECTION (Biological) $170.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Livingston
Dr. Fariborz Rezai, M.d, M.D
Internal Medicine — Payments: $2.7M
Dr. Martin Bedigian, Md, MD
Internal Medicine — Payments: $894,400
Dr. Sridhar Nambi, Md, MD
Internal Medicine — Payments: $152,292
Dr. Noah Rosenberg, Md, MD
Internal Medicine — Payments: $148,109
Dr. Bruce Haik, M.d, M.D
Internal Medicine — Payments: $32,109
Dr. Anna Litvak, Md, MD
Internal Medicine — Payments: $21,218